BioLife Solutions reported third-quarter 2025 results, with revenue of US$28.07 million and net income of US$621,000, also updating its full-year guidance upward after completing the sale of its evo ...
Hosted on MSN
BioLife Solutions raises 2025 revenue guidance to $100M–$103M as cell processing momentum accelerates
CEO Roderick de Greef reported, "We delivered another strong quarter as our team continues to execute and build on the momentum established over the last several quarters." Cell processing revenue ...
BOTHELL, Wash., Aug. 13, 2013 /PRNewswire/ -- BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and ...
TORONTO, ONTARIO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (OTCPK:BLFE) announces it has initiated the process of up-listing to the Over the Counter Quotation Bureau ...
HENDERSON, NV, Aug 10, 2022 – BioLife Sciences Inc. (BioLife), a commercialization accelerator, licensor and developer of technologies, has reportedly provided investors with a significant company ...
TUKWILA, Wash.--(BUSINESS WIRE)--BioLife Plasma Services, part of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, today announced the opening of an all-electric plasma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results